Get started
Author

Jeffrey S. Wefel

Observed names: J. S. Wefel, J. Wefel, J.S. Wefel, Jeffrey Wefel
Observed institutions: The University of Texas MD Anderson Cancer Center, University of California, Los Angeles, Duke University, Genentech, Center for Neuro-Oncology, Johns Hopkins Hospital, National Institute of Mental Health and Neurosciences, Columbia University
ORCID: 0000-0002-3817-2479
Observed ORCID: 0000-0002-3817-2479
OpenAlex ID: A5083176539
RTOG 0525: A randomized phase III trial comparing standard adjuvant temozolomide (TMZ) with a dose-dense (dd) schedule in newly diagnosed glioblastoma (GBM).
2011 · M. R. Gilbert, M. Wang, et al. · Journal of Clinical Oncology · 120
Course of Cognitive Decline in Hematopoietic Stem Cell Transplantation: A Within-subjects Design
2009 · M. A. Friedman, M. Fernandez, et al. · Archives of Clinical Neuropsychology · 50
PDF
Dual Immune Check Point Blockade in MGMT -Unmethylated Newly Diagnosed Glioblastoma: NRG Oncology BN007, a Randomized Phase II/III Clinical Trial
2025 · Andrew B. Lassman, Mei-Yin C. Polley, et al. · Journal of Clinical Oncology · 33
PDF
Memantine for the Prevention of Cognitive Dysfunction in Patients Receiving Whole-brain Radiation Therapy (WBRT): First Report of RTOG 0614, a Placebo-controlled, Double-blind, Randomized Trial
2012 · P.D. Brown, S. Shook, et al. · International Journal of Radiation Oncology*Biology*Physics · 33
PDF
Primary Endpoint Results of NRG CC003: Phase IIR/III Trial of Prophylactic Cranial Irradiation (PCI) with or without Hippocampal Avoidance (HA) for Small Cell Lung Cancer (SCLC)
2023 · V. Gondi, S. Pugh, et al. · International Journal of Radiation Oncology*Biology*Physics · 20
Hippocampal Avoidance During Prophylactic Cranial Irradiation for Patients With Small Cell Lung Cancer: Randomized Phase II/III Trial NRG-CC003
2025 · Vinai Gondi, Stephanie L. Pugh, et al. · Journal of Clinical Oncology · 19
Clinical utility of neurocognitive function (NCF), quality of life (QOL), and symptom assessment as prognostic factors for survival and measures of treatment effects on RTOG 0525.
2011 · T. S. Armstrong, J. S. Wefel, et al. · Journal of Clinical Oncology · 11
Neuro/medical Oncology
2013 · P. Ambady, M. Holdhoff, et al. · Neuro-Oncology · 8
PDF
Nc-12 * Depression and Executive Functioning in Relation to Survival Among Patients With Glioblastoma
2014 · K. Noll, A. Garbarino, et al. · Neuro-Oncology · 6
PDF
Neurocognitive function in patients with glioblastoma multiforme in first or second relapse treated with bevacizumab in the BRAIN study
2009 · J. S. Wefel, T. Cloughesy, et al. · Journal of Clinical Oncology · 5
Prospective neurocognitive evaluation of patients with 1 to 3 newly diagnosed brain metastases treated with stereotactic radiosurgery alone
2004 · E.L. Chang, J.S. Wefel, et al. · International Journal of Radiation Oncology*Biology*Physics · 3
Surgery and tile-based radiation therapy versus surgery and stereotactic radiation for newly diagnosed brain metastases (ROADS): a randomized, open-label, phase 3 trial
2026 · Jeffrey S. Weinberg, Brandon S. Imber, et al. · Journal of Clinical Oncology · 2
Prospective phase II clinical trial of molecular glioblastoma (historical grade 2 and 3 IDH wildtype gliomas) preliminary novel exploratory analyses
2025 · Debra Nana Yeboa, Benjamin T. Whitfield, et al. · Journal of Neuro-Oncology · 2
PDF
NEURO-COGNITIVE
2011 · J. D. S. R. Gonzalez, O. Eduardo, et al. · Neuro-Oncology · 2
PDF
Sex-linked helicases DDX3X and DDX3Y regulate G-quadruplex-associated stress in neurons
2026 · Rocio Diaz Escarcega, Vijay Kumar M. J., et al. · Cell Death and Disease · 1
PDF
Characterization, etiology, and management of neurocognitive impairment in patients with glioma: an evidentiary update
2025 · Kyle R. Noll, Jeffrey S. Wefel · Current Opinion in Neurology · 1
EP-1239: Ph II randomized trial comparing cognitive outcomes of proton vs. photon radiation for glioblastoma
2018 · C. Chung, P. Brown, et al. · Radiotherapy and Oncology · 1
PDF
Nc-15 * Relationships Between Neurocognitive Functioning and Idh1 Genetic Mutation Status in Malignant Astrocytoma
2014 · J. Wefel, K. Noll, et al. · Neuro-Oncology · 1
PDF
PL02.01: SWOG S1827 MAVERICK: Phase III Trial of Brain MRI Surveillance +/- Prophylactic Cranial Irradiation for Small-Cell Lung Cancer
2026 · C.G. Rusthoven, M.W. Redman, et al. · Journal of Thoracic Oncology
The Neuropsychology of Adult Cancers
2026 · Mariana E. Bradshaw, Kyle R. Noll, et al. · Routledge eBooks
WF-1801: Cognitive Outcomes of a Single Arm Pilot Study of Ramipril for Prevention of Radiation-Induced Cognitive Decline in Glioblastoma Patients Receiving Chemoradiotherapy
2025 · A. Goetz, S. Smith, et al. · International Journal of Radiation Oncology*Biology*Physics
PDF
Nc-05 * Association of Neurocognitive and Patient Reported Outcomes With the Presence of Residual Disease Following Surgical Resection in Glioblastoma (gbm)
2014 · W. A. Hall, S. L. Pugh, et al. · Neuro-Oncology
Clin-neuro-cognitive
2012 · J. L. Scotland, I. R. Whittle, et al. · Neuro-Oncology
PDF
Cost-effectiveness analysis based on neurocognitive function of a randomized study with stereotactic radiosurgery (SRS) alone versus SRS plus whole-brain radiation therapy (WBRT) for patients with one to three brain metastases.
2010 · L. Lal, J. S. Wefel, et al. · Journal of Clinical Oncology
Works count: 26
Citation count: 321
H-index: 8
I10-index: 7
Year
Topic
Type